Price target upside
First Tracks Biotherapeutics, Inc. - Ordinary Shares Price Target Upside or Downside
TRAX price target upside based on the current price and analyst average.
Direct answer
First Tracks Biotherapeutics, Inc. - Ordinary Shares's analyst target implies +15.4%.
The average target is $53.25 compared with a recorded current price of $46.13.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 13, 2026.
Get free First Tracks Biotherapeutics, Inc. - Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $46.13
- Average price target
- $53.25
- High price target
- $70.00
- Low price target
- $30.00
- Target upside
- +15.4%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- August 13, 2026
- Valid through
- August 20, 2026